Skip to main content

Advertisement

SpringerLink
Log in

Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The purpose of this study is to determine whether the expressions of MMP-7 and MMP-14 are associated with the ERK 1/2 signaling pathway in human brain gliomas of different pathological grades. Immunohistochemistry and western blot methods were used to determine the expressions of MMP-7, MMP-14 and the phosphorylation status of ERK1/2 in 73 cases of human brain glioma specimens and two cases of normal brain tissues. Results indicated that the protein expression levels of MMP-7, MMP-14 and ERK1/2 phosphorylation level were all elevated with the increasing pathological grades in brain glioma tissues, and correlation assay indicated that the level of ERK1/2 phosphorylation was positively correlated with protein expression levels of MMP-7 and MMP-14 in gliomas of different pathological grades respectively. Moreover, the impact of ERK1/2 inhibitor U0126 on the expressions of MMP-7 and MMP-14 was examined in human U87 glioma cells by western blot analysis. The expressions of MMP-7 and MMP-14 were significantly decreased in human U87 glioma cells after treatment with ERK1/2 inhibitor U0126. The above results suggest that the expressions of MMP-7 and MMP-14 may be associated with activation of ERK1/2 signaling pathway in human brain gliomas of different pathological grades.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer. 2003;3:489–501.

    Article  PubMed  CAS  Google Scholar 

  2. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 2000;10:415–33.

    Article  PubMed  CAS  Google Scholar 

  3. VanMeter TE, et al. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol. 2001;53:213–35.

    Article  PubMed  CAS  Google Scholar 

  4. Ma Z, Qin H, Benveniste EN. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol. 2001;167:5150–9.

    PubMed  CAS  Google Scholar 

  5. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 1999;189:300–8.

    Article  PubMed  CAS  Google Scholar 

  6. Stetler-Stevenson WG, Hewitt R, Corcoran M. Matrixmetalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol. 1996;7:147–54.

    Article  PubMed  CAS  Google Scholar 

  7. Misugi F, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis. Int J Mol Med. 2005;16:541–6.

    PubMed  CAS  Google Scholar 

  8. Ichikawa Y, et al. Function of MMP-7 in colorectal cancer. Nippon Rinsho. 2003;61:209–14.

    PubMed  Google Scholar 

  9. Lee KH, et al. Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma. Oncol Rep. 2006;16:823–30.

    PubMed  CAS  Google Scholar 

  10. Liu D, et al. Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer. Lung Cancer. 2007;58:384–91.

    Article  PubMed  Google Scholar 

  11. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood). 2006;231:20–7.

    CAS  Google Scholar 

  12. Maquoi E, et al. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. J Biol Chem. 2000;275:11368–78.

    Article  PubMed  CAS  Google Scholar 

  13. Shim KN, Jung SA, Joo YH, Yoo K. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. J Gastroenterol. 2007;42:120–8.

    Article  PubMed  CAS  Google Scholar 

  14. Ellenrieder V, et al. Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer. 2000;85:14–20.

    Article  PubMed  CAS  Google Scholar 

  15. Adley BP, Gleason KJ, Yang XJ, Stack MS. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma. Gynecol Oncol. 2009;112:319–24.

    Article  PubMed  CAS  Google Scholar 

  16. de Vicente JC, Leguerica-Fernández P, Santamaría J, Fresno MF. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. J Oral Pathol Med. 2007;36:415–24.

    Article  PubMed  Google Scholar 

  17. Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 2003;22:395–403.

    Article  PubMed  CAS  Google Scholar 

  18. Kunapuli P, Kasyapa CS, Hawthorn L, Cowell JK. LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway. J Biol Chem. 2004;279:23151–7.

    Article  PubMed  CAS  Google Scholar 

  19. Kim JH, Choi C, Benveniste EN, Kwon D. TRAIL induces MMP-9 expression via ERK activation in human astrocytoma cells. Biochem Biophys Res Commun. 2008;377:195–9.

    Article  PubMed  CAS  Google Scholar 

  20. Rome C, Arsaut J, Taris C, Couillaud F, Loiseau H. MMP-7 (Matrilysin) expression in human brain tumors. Mol Carcinog. 2007;46:446–52.

    Article  PubMed  CAS  Google Scholar 

  21. Nakada M, et al. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol. 1999;154:417–28.

    Article  PubMed  CAS  Google Scholar 

  22. Guo P, et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane Type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol. 2005;166:877–90.

    Article  PubMed  CAS  Google Scholar 

  23. Inamoto T, et al. Invasive ability of human renal cell carcinoma cell line Caki-2 is accelerated by gamma-aminobutyric acid, via sustained activation of ERK1/2 inducible matrix metalloproteinases. Cancer Invest. 2007;25:574–83.

    Article  PubMed  CAS  Google Scholar 

  24. Jelinek T, Dent P, Sturgill TW, Weber MJ. Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation. Mol Cell Biol. 1996;16:1027–34.

    PubMed  CAS  Google Scholar 

  25. Kaomongkolgit R, Cheeosunthorn P, Pavasant P, Sanchavanakit N. Iron increase MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells. Oral Oncol. 2008;44:587–94.

    Article  PubMed  CAS  Google Scholar 

  26. Lee SJ, et al. Activation of matrix metalloproteinase-9 by TNF-α in human urinary bladder cancer HT1376 cells: The role of MAP kinase signaling pathways. Oncol Rep. 2008;19:1007–13.

    PubMed  CAS  Google Scholar 

  27. Tan CT, et al. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Carcinogenesis. 2008;29:1519–27.

    Article  PubMed  CAS  Google Scholar 

  28. Lopez-Gines C, et al. The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification. Neuropathology. 2008;28:507–15.

    Article  PubMed  Google Scholar 

  29. Bhaskara VK, Panigrahi M, Challa S, Babu PP. Comparative status of activated ERK1/2 and PARP cleavage in human gliomas. Neuropathology. 2005;25:48–53.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Natural Science Foundation of China, under contract numbers 30800451, 30872656, 30700861, 30670723, and 30973079; Scientific and Technological Research Projects in Colleges and Universities of Liaoning Province, number 2008850; the special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities, number 20092104110015; and Scientific and Technological Planning Projects of Shenyang, numbers 1072033-1-00 and 1081266-9-00.

Author information

Authors and Affiliations

  1. Department of Neurobiology, College of Basic Medicine, China Medical University, 110001, Shenyang, Liaoning Province, People’s Republic of China

    Hui Xie, Yi-xue Xue, Li-bo Liu & Ping Wang

  2. Department of Neurosurgery, Shengjing Hospital of China Medical University, 110004, Shenyang, Liaoning Province, People’s Republic of China

    Yun-hui Liu & Hao-qiang Ying

Authors
  1. Hui Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi-xue Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Li-bo Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yun-hui Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hao-qiang Ying
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi-xue Xue.

Additional information

Hui Xie, Yi-xue Xue contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, H., Xue, Yx., Liu, Lb. et al. Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades. Med Oncol 28 (Suppl 1), 433–438 (2011). https://doi.org/10.1007/s12032-010-9660-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-010-9660-7

Keywords

Search

Navigation